Incannex completes dosing and therapy in phase 2 “psigad” clinical trial assessing psilocybin-assisted psychotherapy for generalized anxiety disorder; data analysis commences

Highlights: 72 patients treated at purpose-built facilities within monash university, melbourne, australia. topline results from the trial anticipated within current q1 2024.

IXHL Ratings Summary

IXHL Quant Ranking